Zenrelia (ilunocitinib Tablet) for Dogs - 6.4 mg - 30 Count or 90 Count
Product Details: Zenrelia (ilunocitinib tablets) is indicated for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. This product is an oral tablet formulation. Zenrelia relieves itching in dogs due to allergic dermatitis and controls atopic dermatitis Zenrelia works fast, providing visible improvements in itch* Ilunocitinib, the active ingredient in Zenrelia, works by reducing the itch and inflammatory response in your dog's skin due to allergies The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert, including the Boxed Warning, for additional information The once-daily tablet can be given with or without food from the comfort of your home Warning: Inadequate immune response to vaccines based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. See Warnings and Target Animal Safety in the manufacturer product insert for detailed information. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. See Warnings and Target Animal Safety in the manufacturer product insert for detailed information. Allergic dermatitis can make your dog very uncomfortable. Symptoms like excessive itching, scratching, and biting aren't only disruptive to you and your pet, but they can also cause more severe problems over time, including hair loss and skin infection. Zenrelia (ilunocitinib tablets) is a once-daily tablet that relieves itching due to allergic dermatitis and controlsatopic dermatitis. Zenrelia is designed to begin working rapidly.* The active ingredient, ilunocitinib, reduces the inflammatory response in your dog's skin caused by allergies, making your dog feel less itchy. What's more, Zenrelia is designed to deliver continuous efficacy over the long term and can get your dog back to normal**. Dogs should not take Zenrelia for at least 28 days to 3 months prior to vaccination and should not take Zenrelia for at least 28 days after vaccination. Discuss your dog's vaccine schedule with your veterinarian. Zenrelia is given once a day with or without food, so it may be easier to incorporate into your daily routine. Always follow your veterinarian's instructions. The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert including the Boxed Warning. Zenrelia is a prescription itch relief medication for dogs at least 12 months of age. Ask your veterinarian if Zenrelia can relieve itching in your dog due to allergic and atopic dermatitis. Fast relief for your best friend is also a relief for you. Spend more time doing the things you love, like cuddling and playing, and less time managing your dog's allergy symptoms. References: *Forster S, Boegel A, Despa S, et al. Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. Veterinary Dermatology. 2025; 1-10 **Clinical remission of itch demonstrated by a Normal-PVAS Please note: The images provided are for illustrative purposes. Your product may be delivered in a Vetsource Pharmacy vial; product packaging & appearance may vary and are subject to manufacturer availability. Product sourced directly from the manufacturer or their approved distributor. Guaranteed genuine product backed by the manufacturer. For: Dogs (at least 12 months of age and weighing 6.6 lbs and over) Brand Name: Zenrelia Drug Class: Janus kinase (JAK) inhibitor, Immunomodulator Product Strength & Size: Zenrelia tablets may be available in multiple strengths and or sizes. Please ensure the selected product and package size are appropriate for your pet, as recommended by your veterinarian. For current availability, please refer to the product selection above. Manufacturer: Elanco Active Ingredients: Ilunocitinib Inactive Ingredients: Complete inactive ingredients list not provided by manufacturer. Usage: *For complete product information, please review the full prescribing information in the manufacturer package insert. Zenrelia should be given orally once daily, as prescribed by your veterinarian. Wash your hands thoroughly with soap and water immediately after handling the medication. Please consult your veterinarian before making any changes or discontinuing the prescribed dosing schedule. Contact your veterinarian if your pet's condition worsens or does not improve after starting the medication. Zenrelia can be administered with or without food. If your pet vomits or appears unwell after receiving a dose on an empty stomach, give future doses with food or a small treat. If vomiting continues, contact your veterinarian. Missed Doses: Administer the dose as soon as possible. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not give more medication than prescribed or two doses at once. If you have questions about your pet's prescribed dosing schedule (e.g., timing, interval), please consult your veterinarian. Side Effects: The most common side effects reported with this medication are vomiting, diarrhea, and lethargy (tiredness). Contact your veterinarian immediately if you notice signs of an infection (e.g., coughing wheezing, bleeding or oozing skin sores, painful frequent urination, etc.), anynew and abnormal skin changes growths, or enlargement of existing skin masses. This is not a complete list of possible side effects; please refer to the manufacturer's product insert for more information. Notify your veterinarian if your pet experiences any of the effects described above, or if you notice any other side effects that are persistent or troublesome. If you notice anything unusual, please consult your veterinarian. Precautions: *For complete product information including warnings and precautions, please refer to the manufacturer package insert. Read the entire package insert, including the Boxed Warning, before using this drug. For oral use in dogs only-not for use in humans. Zenrelia is not for use in dogs less than 12 months of age. Due to the risk of infections, dogs should be up to date on vaccinations prior to starting Zenrelia. (see Boxed Warning). Do NOT use Zenrelia in dogs with serious infections. Consider the risks and benefits of treatment prior to initiating Zenrelia in dogs with a history of recurrent serious infections or recurrent demodicosis or neoplasia. Wash your hands immediately after handling this medication. In case of accidental eye contact, flush immediately with water or saline for at least 15 minutes, then seek medical attention. In case of accidental ingestion, seek medical attention immediately. The safe use of Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs. Discuss the risks of using this medication with your veterinarian prior to use if your pet is in one of these groups. Do not administer this medication to animals with a known or suspected allergy hypersensitivity to it or any of its ingredients. Allergic reactions to medications may occur. Please inform Vetsource and your veterinarian if your pet has any known sensitivities or allergies, especially to medications and supplements. If your pet displays symptoms of an allergic reaction, discontinue therapy and callView details
Zenrelia (Ilunocitinib Tablet) for Dogs - 8.5 mg - 30 Count or 90 Count
Product Details: Zenrelia (ilunocitinib tablets) is indicated for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. This product is an oral tablet formulation. Zenrelia relieves itching in dogs due to allergic dermatitis and controls atopic dermatitis Zenrelia works fast, providing visible improvements in itch* Ilunocitinib, the active ingredient in Zenrelia, works by reducing the itch and inflammatory response in your dog's skin due to allergies The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert, including the Boxed Warning, for additional information The once-daily tablet can be given with or without food from the comfort of your home Warning: Inadequate immune response to vaccines based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. See Warnings and Target Animal Safety in the manufacturer product insert for detailed information. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. See Warnings and Target Animal Safety in the manufacturer product insert for detailed information. Allergic dermatitis can make your dog very uncomfortable. Symptoms like excessive itching, scratching, and biting aren't only disruptive to you and your pet, but they can also cause more severe problems over time, including hair loss and skin infection. Zenrelia (ilunocitinib tablets) is a once-daily tablet that relieves itching due to allergic dermatitis and controlsatopic dermatitis. Zenrelia is designed to begin working rapidly.* The active ingredient, ilunocitinib, reduces the inflammatory response in your dog's skin caused by allergies, making your dog feel less itchy. What's more, Zenrelia is designed to deliver continuous efficacy over the long term and can get your dog back to normal**. Dogs should not take Zenrelia for at least 28 days to 3 months prior to vaccination and should not take Zenrelia for at least 28 days after vaccination. Discuss your dog's vaccine schedule with your veterinarian. Zenrelia is given once a day with or without food, so it may be easier to incorporate into your daily routine. Always follow your veterinarian's instructions. The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert including the Boxed Warning. Zenrelia is a prescription itch relief medication for dogs at least 12 months of age. Ask your veterinarian if Zenrelia can relieve itching in your dog due to allergic and atopic dermatitis. Fast relief for your best friend is also a relief for you. Spend more time doing the things you love, like cuddling and playing, and less time managing your dog's allergy symptoms. References: *Forster S, Boegel A, Despa S, et al. Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. Veterinary Dermatology. 2025; 1-10 **Clinical remission of itch demonstrated by a Normal-PVAS Please note: The images provided are for illustrative purposes. Your product may be delivered in a Vetsource Pharmacy vial; product packaging & appearance may vary and are subject to manufacturer availability. Product sourced directly from the manufacturer or their approved distributor. Guaranteed genuine product backed by the manufacturer. For: Dogs (at least 12 months of age and weighing 6.6 lbs and over) Brand Name: Zenrelia Drug Class: Janus kinase (JAK) inhibitor, Immunomodulator Product Strength & Size: Zenrelia tablets may be available in multiple strengths and or sizes. Please ensure the selected product and package size are appropriate for your pet, as recommended by your veterinarian. For current availability, please refer to the product selection above. Manufacturer: Elanco Active Ingredients: Ilunocitinib Inactive Ingredients: Complete inactive ingredients list not provided by manufacturer. Usage: *For complete product information, please review the full prescribing information in the manufacturer package insert. Zenrelia should be given orally once daily, as prescribed by your veterinarian. Wash your hands thoroughly with soap and water immediately after handling the medication. Please consult your veterinarian before making any changes or discontinuing the prescribed dosing schedule. Contact your veterinarian if your pet's condition worsens or does not improve after starting the medication. Zenrelia can be administered with or without food. If your pet vomits or appears unwell after receiving a dose on an empty stomach, give future doses with food or a small treat. If vomiting continues, contact your veterinarian. Missed Doses: Administer the dose as soon as possible. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not give more medication than prescribed or two doses at once. If you have questions about your pet's prescribed dosing schedule (e.g., timing, interval), please consult your veterinarian. Side Effects: The most common side effects reported with this medication are vomiting, diarrhea, and lethargy (tiredness). Contact your veterinarian immediately if you notice signs of an infection (e.g., coughing wheezing, bleeding or oozing skin sores, painful frequent urination, etc.), anynew and abnormal skin changes growths, or enlargement of existing skin masses. This is not a complete list of possible side effects; please refer to the manufacturer's product insert for more information. Notify your veterinarian if your pet experiences any of the effects described above, or if you notice any other side effects that are persistent or troublesome. If you notice anything unusual, please consult your veterinarian. Precautions: *For complete product information including warnings and precautions, please refer to the manufacturer package insert. Read the entire package insert, including the Boxed Warning, before using this drug. For oral use in dogs only-not for use in humans. Zenrelia is not for use in dogs less than 12 months of age. Due to the risk of infections, dogs should be up to date on vaccinations prior to starting Zenrelia. (see Boxed Warning). Do NOT use Zenrelia in dogs with serious infections. Consider the risks and benefits of treatment prior to initiating Zenrelia in dogs with a history of recurrent serious infections or recurrent demodicosis or neoplasia. Wash your hands immediately after handling this medication. In case of accidental eye contact, flush immediately with water or saline for at least 15 minutes, then seek medical attention. In case of accidental ingestion, seek medical attention immediately. The safe use of Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs. Discuss the risks of using this medication with your veterinarian prior to use if your pet is in one of these groups. Do not administer this medication to animals with a known or suspected allergy hypersensitivity to it or any of its ingredients. Allergic reactions to medications may occur. Please inform Vetsource and your veterinarian if your pet has any known sensitivities or allergies, especially to medications and supplements. If your pet displays symptoms of an allergic reaction, discontinue therapy and callView details
Zenrelia (ilunocitinib tablets) for Dogs - 15mg - 30 Count or 90 Count
Zenrelia (ilunocitinib tablets) for Dogs - 4.8 mg - 30 Count or 90 Count
Product Details: Zenrelia (ilunocitinib tablets) is indicated for control of pruritus (itching) associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age. This product is an oral tablet formulation. Zenrelia relieves itching in dogs due to allergic dermatitis and controls atopic dermatitis Zenrelia works fast, providing visible improvements in itch* Ilunocitinib, the active ingredient in Zenrelia, works by reducing the itch and inflammatory response in your dog's skin due to allergies The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert, including the Boxed Warning, for additional information The once-daily tablet can be given with or without food from the comfort of your home Warning: Inadequate immune response to vaccines based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. See Warnings and Target Animal Safety in the manufacturer product insert for detailed information. Based on results of the vaccine response study, dogs receiving Zenrelia are at risk of an inadequate immune response to vaccines. Discontinue Zenrelia for at least 28 days to 3 months prior to vaccination and withhold Zenrelia for at least 28 days after vaccination. See Warnings and Target Animal Safety in the manufacturer product insert for detailed information. Allergic dermatitis can make your dog very uncomfortable. Symptoms like excessive itching, scratching, and biting aren't only disruptive to you and your pet, but they can also cause more severe problems over time, including hair loss and skin infection. Zenrelia (ilunocitinib tablets) is a once-daily tablet that relieves itching due to allergic dermatitis and controlsatopic dermatitis. Zenrelia is designed to begin working rapidly.* The active ingredient, ilunocitinib, reduces the inflammatory response in your dog's skin caused by allergies, making your dog feel less itchy. What's more, Zenrelia is designed to deliver continuous efficacy over the long term and can get your dog back to normal**. Dogs should not take Zenrelia for at least 28 days to 3 months prior to vaccination and should not take Zenrelia for at least 28 days after vaccination. Discuss your dog's vaccine schedule with your veterinarian. Zenrelia is given once a day with or without food, so it may be easier to incorporate into your daily routine. Always follow your veterinarian's instructions. The most common side effects reported with this dog dermatitis treatment were vomiting, diarrhea and tiredness; see package insert including the Boxed Warning. Zenrelia is a prescription itch relief medication for dogs at least 12 months of age. Ask your veterinarian if Zenrelia can relieve itching in your dog due to allergic and atopic dermatitis. Fast relief for your best friend is also a relief for you. Spend more time doing the things you love, like cuddling and playing, and less time managing your dog's allergy symptoms. References: *Forster S, Boegel A, Despa S, et al. Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis. Veterinary Dermatology. 2025; 1-10 **Clinical remission of itch demonstrated by a Normal-PVAS Please note: The images provided are for illustrative purposes. Your product may be delivered in a Vetsource Pharmacy vial; product packaging & appearance may vary and are subject to manufacturer availability. Product sourced directly from the manufacturer or their approved distributor. Guaranteed genuine product backed by the manufacturer. For: Dogs (at least 12 months of age and weighing 6.6 lbs and over) Brand Name: Zenrelia Drug Class: Janus kinase (JAK) inhibitor, Immunomodulator Product Strength & Size: Zenrelia tablets may be available in multiple strengths and or sizes. Please ensure the selected product and package size are appropriate for your pet, as recommended by your veterinarian. For current availability, please refer to the product selection above. Manufacturer: Elanco Active Ingredients: Ilunocitinib Inactive Ingredients: Complete inactive ingredients list not provided by manufacturer. Usage: *For complete product information, please review the full prescribing information in the manufacturer package insert. Zenrelia should be given orally once daily, as prescribed by your veterinarian. Wash your hands thoroughly with soap and water immediately after handling the medication. Please consult your veterinarian before making any changes or discontinuing the prescribed dosing schedule. Contact your veterinarian if your pet's condition worsens or does not improve after starting the medication. Zenrelia can be administered with or without food. If your pet vomits or appears unwell after receiving a dose on an empty stomach, give future doses with food or a small treat. If vomiting continues, contact your veterinarian. Missed Doses: Administer the dose as soon as possible. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not give more medication than prescribed or two doses at once. If you have questions about your pet's prescribed dosing schedule (e.g., timing, interval), please consult your veterinarian. Side Effects: The most common side effects reported with this medication are vomiting, diarrhea, and lethargy (tiredness). Contact your veterinarian immediately if you notice signs of an infection (e.g., coughing wheezing, bleeding or oozing skin sores, painful frequent urination, etc.), anynew and abnormal skin changes growths, or enlargement of existing skin masses. This is not a complete list of possible side effects; please refer to the manufacturer's product insert for more information. Notify your veterinarian if your pet experiences any of the effects described above, or if you notice any other side effects that are persistent or troublesome. If you notice anything unusual, please consult your veterinarian. Precautions: *For complete product information including warnings and precautions, please refer to the manufacturer package insert. Read the entire package insert, including the Boxed Warning, before using this drug. For oral use in dogs only-not for use in humans. Zenrelia is not for use in dogs less than 12 months of age. Due to the risk of infections, dogs should be up to date on vaccinations prior to starting Zenrelia. (see Boxed Warning). Do NOT use Zenrelia in dogs with serious infections. Consider the risks and benefits of treatment prior to initiating Zenrelia in dogs with a history of recurrent serious infections or recurrent demodicosis or neoplasia. Wash your hands immediately after handling this medication. In case of accidental eye contact, flush immediately with water or saline for at least 15 minutes, then seek medical attention. In case of accidental ingestion, seek medical attention immediately. The safe use of Zenrelia has not been evaluated in breeding, pregnant, or lactating dogs. Discuss the risks of using this medication with your veterinarian prior to use if your pet is in one of these groups. Do not administer this medication to animals with a known or suspected allergy hypersensitivity to it or any of its ingredients. Allergic reactions to medications may occur. Please inform Vetsource and your veterinarian if your pet has any known sensitivities or allergies, especially to medications and supplements. If your pet displays symptoms of an allergic reaction, discontinue therapy and call your vetView details